<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03070210</url>
  </required_header>
  <id_info>
    <org_study_id>16-1543</org_study_id>
    <nct_id>NCT03070210</nct_id>
  </id_info>
  <brief_title>Clinical Trial to Evaluate the Endoscopic Ultrasound Guided Celiac Plexus Block for Treatment of Pain in Chronic Pancreatitis</brief_title>
  <official_title>A Randomized, Controlled Trial of Endoscopic Ultrasound Guided Celiac Plexus Blockade (EUS-CPB) With Standard Plexus Injection vs. Direct Celiac Ganglia Block for Treatment of Pain in Chronic Pancreatitis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      AIM: To compare pain relief in patients randomly assigned to endoscopic ultrasound-guided
      celiac ganglia block (EUS-CGB) vs standard endoscopic ultrasound-guided celiac plexus block
      (EUS-CPB).

      METHODS: This is a single-center, double-blind, randomized parallel-group study to assess the
      efficacy of EUS-CPB vs. EUS-CGB in patients with painful chronic pancreatitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria include: age&gt;18 yrs, ability for informed consent, chronic daily
      pancreatic-type abdominal pain.

      Exclusion criteria include: pregnancy, malignancy, recent acute pancreatitis (within 2
      months), elevated INR (&gt;1.5) or low platelet count (&lt;75 cells/mm3), allergy to eggs or
      &quot;caine&quot; anesthetics.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 25, 2017</start_date>
  <completion_date type="Anticipated">August 25, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 25, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain relief</measure>
    <time_frame>1 week</time_frame>
    <description>The primary endpoint will be pain relief at 1 week after the block, defined as a decrease of 3 or more points in the VAS scale measuring &quot;average pain over past week&quot;.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complete response rate</measure>
    <time_frame>1 week</time_frame>
    <description>Decrease in pain to 1 or 0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of pain relief</measure>
    <time_frame>up to 2 months</time_frame>
    <description>Duration of pain relief will be assessed during a 2-month follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>up to 2 months</time_frame>
    <description>Assess the opioid consumption in up to 2 months after endoscopic therapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>in up to 2 months</time_frame>
    <description>Assess the incidence of adverse effects after endoscopic therapy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">86</enrollment>
  <condition>Pancreatitis, Chronic</condition>
  <condition>Abdominal Pain</condition>
  <arm_group>
    <arm_group_label>EUS-celiac plexus block (EUS-CPB)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This is the standard technique. In this approach, the needle is passed through the body of the stomach adjacent the celiac artery into the retroperitoneal space in 1 or 2 passes. The injectate (bupivacaine or alcohol) is injected and spreads through the retroperitoneal space, effectively &quot;bathing&quot; all the ganglia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EUS-celiac ganglia block (EUS-CGB)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This is a more recent technique which has been often used. In this procedure, the needle is inserted under EUS guidance directly into as many ganglia as possible. For celiac ganglia &lt;1cm in diameter, the solution is injected into the central point; for those â‰¥1 cm, a needle is advanced to the deepest point into the ganglia and solution is injected as the needle is slowly withdrawn. Injections are continued until an echogenic pattern is produced over the entire celiac ganglia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EUS-celiac ganglia block (EUS-CGB)</intervention_name>
    <description>The intervention technique of EUS-CGB is the realization of EUS-guided celiac block with injection of bupivacaine directly into the ganglia for patients with chronic pancreatitis.</description>
    <arm_group_label>EUS-celiac ganglia block (EUS-CGB)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EUS-celiac plexus block (EUS-CPB)</intervention_name>
    <description>In the arm of EUS-CPB, the procedure is going to be performed with the standard EUS-guided celiac plexus block with injection of bupivacaine into the retroperitoneal space.</description>
    <arm_group_label>EUS-celiac plexus block (EUS-CPB)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with chronic pancreatitis and referred for EUS-guided celiac plexus block
             with: age&gt;18 yrs, ability for informed consent, chronic daily pancreatic-type
             abdominal pain.

        Exclusion Criteria:

          -  pregnancy, malignancy, recent acute pancreatitis (within 2 months), elevated INR
             (&gt;1.5) or low platelet count (&lt;75 cells/mm3), allergy to eggs or &quot;caine&quot; anesthetics.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tyler Stevens, MD</last_name>
    <role>Study Director</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tyler Stevens, MD</last_name>
    <phone>(216) 445-1996</phone>
    <email>STEVENT@ccf.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cleveland Clinic Main Campus</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tyler Stevens, MD</last_name>
      <phone>216-213-0494</phone>
      <email>stevent@ccf.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Doi S, Yasuda I, Kawakami H, Hayashi T, Hisai H, Irisawa A, Mukai T, Katanuma A, Kubota K, Ohnishi T, Ryozawa S, Hara K, Itoi T, Hanada K, Yamao K. Endoscopic ultrasound-guided celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multicenter trial. Endoscopy. 2013;45(5):362-9. doi: 10.1055/s-0032-1326225. Epub 2013 Apr 24.</citation>
    <PMID>23616126</PMID>
  </reference>
  <reference>
    <citation>Ascunce G, Ribeiro A, Reis I, Rocha-Lima C, Sleeman D, Merchan J, Levi J. EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy (with video). Gastrointest Endosc. 2011 Feb;73(2):267-74. doi: 10.1016/j.gie.2010.10.029.</citation>
    <PMID>21295640</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2017</study_first_submitted>
  <study_first_submitted_qc>February 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2017</study_first_posted>
  <last_update_submitted>March 9, 2018</last_update_submitted>
  <last_update_submitted_qc>March 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Tyler Stevens</investigator_full_name>
    <investigator_title>Director of Advanced Endoscopy Fellowship Program</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Abdominal Pain</mesh_term>
    <mesh_term>Pancreatitis, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

